Impact of Covid-19 Pandemic on Antimicrobial Resistance (AMR):
An opinion

Pharmaceutical Drug Regulatory Affairs Journal Opinion 1 min read

Maqbool M^*

^* Corresponding author

ISSN: 2642-6315 10.23880/pdraj-16000122 Received: August 19, 2021 Published: August 25, 2021

— views

10 references

PDF

References

Malik JA, Maqbool M (2020) COVID-19: An overview of current scenario. Cellmed 10(3): 21.1-21.8.
WHO(2019) Antimicrobial resistance: World Health Organization.
Hsu J (2020) How covid-19 is accelerating the threat of antimicrobial resistance. BMJ pp: 369.
Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, et al. (2020) Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases 71(9): 2459-2468.
WHO (2020) Clinical management of COVID-19: interim guidance, Geneva: World Health Organization, pp: 62.
Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH (2020) Tackling antimicrobial resistance in the COVID-19 pandemic. Bulletin of the World Health Organization 98(7): 442-442A.
Caselli E (2017) Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings. Microbial Biotechnology 10(5): 1079-1083.
Kampf G (2018) Biocidal agents used for disinfection can enhance antibiotic resistance in gram-negative species. Antibiotics 7(4): 110.
Murray AK (2020) The novel coronavirus COVID-19 outbreak: global implications for antimicrobial resistance. Frontiers in microbiology 11: 1020.
Mazdeyasna H, Nori P, Patel P, Doll M, Godbout E, et al. (2020) Antimicrobial stewardship at the core of COVID-19 response efforts: implications for sustaining and building programs. Current infectious disease reports 22(9): 1-6.